Navigation Links
Genstar Capital Appoints Mark Hanson to Managing Director
Date:12/21/2007

Firm's focus On Software & Software Services Yields Two Recent Transactions

SAN FRANCISCO, Dec. 21 /PRNewswire/ -- Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of life sciences, healthcare services, industrial technology, software and software services, today announced the appointment of Mark Hanson as a Managing Director.

"We have been extremely pleased with Mark's leadership with two significant software and software services transactions since he joined our team one year ago as Operating Partner," said Jean-Pierre L. Conte, Chairman and Managing Director of Genstar. "Mark has extraordinary operational expertise with both large organizations as well as smaller, highly entrepreneurial businesses where he helped to successfully build the operations of a number of companies. We believe his experience and insights in the software industry and his intense operating background will help us to identify additional investment opportunities in what has become a core investment sector for Genstar and create superior returns for our investors."

Mr. Hanson joined Genstar as an Operating Partner in 2006 with more than 24 years of experience in the software industry and leads the firm's investments in Software and Software Services. Prior to joining Genstar, Mr. Hanson served as Senior Vice President for Corporate Development and Chief of Staff for Siebel Systems, Inc., where he worked closely with the executive team to help the company return to growth in 2005. He was responsible for building the M&A function at Siebel and during his tenure the company made 17 acquisitions. Prior to that, he was President and Chief Operating Officer of Visigenic Software, Inc., a company he helped build from a startup entity with no revenues, through its IPO and sale to Borland Software Corporation. He also worked as a senior executive with other leading software companies, including Sybase, Inc., Macromedia, Inc., and Informix Software, Inc. Mr. Hanson is a graduate of Santa Clara University and received his MBA degree from Golden Gate University.

Genstar has completed two acquisitions in 2007 in the software and software services sectors, including the purchase of ConvergeOne, one of the largest independent providers of business communications solutions in the U.S. and TravelCLICK, a leading global provider of interactive distribution solutions and marketing services to independent and chain hotels worldwide.

About Genstar Capital, LLC

Based in San Francisco, Genstar Capital (http://www.gencap.com) is a private equity investment firm that makes leveraged investments in quality middle- market companies. Genstar Capital works in partnership with management to transform its portfolio companies into industry-leading businesses. With more than $3 billion of committed capital under management and significant experience investing in businesses, Genstar focuses on selected segments of life sciences, healthcare services, industrial technology, software and software services.


'/>"/>
SOURCE Genstar Capital, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. AtriCure to Present at Roth Capital Partners 2007 New York Conference
3. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
4. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
5. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
6. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. Advanced Life Sciences Joins NASDAQ Capital Market
9. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
10. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
11. Caxton-Iseman Capital Acquires Conney Safety Products, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: